Scientific Games Corp. agreed to acquire slot-machine maker Bally Technologies, Inc. (NYSE:BYI) for about $3.3 billion, furthering a consolidation of the gaming-equipment industry. Bally shareholders will get $83.30 a share, representing a 38% premium to the stock’s closing price on Thursday. Bally Technologies, Inc. (NYSE:BYI) belongs to Services sector. Its net profit margin is 10.90% and weekly performance is 24.80%. On last trading day company shares ended up $77.70. Bally Technologies, Inc. (NYSE:BYI) distance from 50-day simple moving average (SMA50) is 25.74%.

TheStreet Ratings rates CSX Corp. (NYSE:CSX) as a buy. The company’s strengths can be seen in multiple areas, such as its solid stock price performance, revenue growth, reasonable valuation levels, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. CSX Corp. (NYSE:CSX) shares fell -1.10% in last trading session and ended the day at $29.59. CSX Gross Margin is 66.30% and its return on assets is 5.70%. CSX Corp. (NYSE:CSX) quarterly performance is 6.90%.

One stock that might be an intriguing choice for investors right now is Snap-on Incorporated (NYSE:SNA). This is because this security in the Tools-Hand Held space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. On 01 August, Snap-on Incorporated (NYSE:SNA) shares fell -0.37% and was closed at $119.75. SNA EPS growth in last 5 year was 7.80%. Snap-on Incorporated (NYSE:SNA) year to date (YTD) performance is 10.22%.

On August 1, 2014, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued a press release reporting our financial results for the second quarter ended June 30, 2014. The full text of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) ended the last trading day at $4.46. Company weekly volatility is calculated as 5.33%and price to cash ratio as 3.82. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed a weekly performance of -6.50%.

Greenhill & Co., Inc. (NYSE:GHL) the advisory firm whose shares have underperformed larger rivals this year, rose the most in 30 months after reporting second-quarter profit that beat analysts’ estimates. Greenhill & Co., Inc. (NYSE:GHL) shares fell -0.92% in last trading session and ended the day on $45.35. GHL Gross Margin is 97.70% and its return on assets is 7.70%. Greenhill & Co., Inc. (NYSE:GHL) quarterly performance is -9.84%.